The purpose of this study is to examine the effects of etanercept (10 mg and 25 mg) compared with methotrexate (up to 8 mg per week) on the slowing of joint destruction.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00445770?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
